ANGELA DUNCAN: Open Payments
NPI 1366042202 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 24 payments from 9 companies in 2025. Trend: 2023 $470 · 2024 $971 · 2025 $621
Food & beverage: $521Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $185 |
| Astellas Pharma US Inc | 4 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Corcept Therapeutics | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| KYOWA KIRIN, INC. | 1 | $14 |
Products named: OPDIVO, Fabhalta, PLUVICTO, LYNPARZA, Vyloy, LUTATHERA, Korlym, BLENREP.
Industry payments across IL — which companies pay providers there.
